206 reports of this reaction
3.1% of all DESVENLAFAXINE reports
#4 most reported adverse reaction
NAUSEA is the #4 most commonly reported adverse reaction for DESVENLAFAXINE, manufactured by Actavis Pharma, Inc.. There are 206 FDA adverse event reports linking DESVENLAFAXINE to NAUSEA. This represents approximately 3.1% of all 6,688 adverse event reports for this drug.
Patients taking DESVENLAFAXINE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among DESVENLAFAXINE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for DESVENLAFAXINE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 206 FDA reports for DESVENLAFAXINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.1% of all adverse event reports for DESVENLAFAXINE, making it a notable side effect.
If you experience nausea while taking DESVENLAFAXINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.